Stay updated on Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.

Latest updates to the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page
- Check4 days agoChange DetectedThe Publications section now includes the extended follow-up Lancet Oncology article for CheckMate 214 and its erratum, replacing the previous 2019 Lancet Oncology citation.SummaryDifference0.0%

- Check11 days agoChange Detected- Minor platform version update from Revision: v3.4.1 to v3.4.2; no user-visible changes to study details or layout observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedAdded a 2019 Lancet Oncology publication on patient-reported outcomes for CheckMate 214 and removed the Erratum reference for that publication.SummaryDifference0.0%

- Check32 days agoChange DetectedUI label additions for Show glossary / Hide glossary were introduced, along with minor wording/capitalization changes in QC-related text (Last Update Submitted that Met QC Criteria and No FEAR Act Data). A new site revision tag 'Revision: v3.4.0' appears, replacing the previous version.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision labels updated from v3.3.3 to v3.3.4 on the page, with no changes to study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedPublication citation for the CheckMate 214 study was updated: a Lancet Oncology 2019 article entry was added with an erratum, and the previous version was removed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.